TimesMachine is an exclusive benefit for home delivery and digital subscribers. Full text is unavailable for this digitized archive article. Subscribers may view the full text of this article in ...

In addition, there are technological limitations to using this technology on body cameras," Axon said in 2019. "Consistent ...

Microsoft (NASDAQ:MSFT) and Quantinuum have leapt one step closer to commercializing quantum computing through greatly reducing error rates associated with qubits ...

Transform your research into commercial biomedical products with this revised and updated second edition. Covering drugs, devices and diagnostics, this book provides a step-by-step introduction to the ...

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and ...

The company is engaged in discovering, developing, commercializing and expertise its novel and proprietary technologies with a focus to provide unmet medical needs through a range of develops ...

Generated first quarter 2024 total revenue of $19.3 million, an increase of 2% compared to the same period in the prior year. Achieved total gross margin of 86% in the first quarter of 2024 compared ...

Revolutionizes cushioning with high-elasticity biomass-based materials Unified domestic industries go beyond performance to ...

The company said Series C funding enables it to expand three new business lines: preventative maintenance, virtual vehicle ...

(Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that the ...

MALVERN, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and ...